Optimizing Maternal and Fetal Antibody Exposure and Dosing Regimens During Pregnancy Using a Physiologically Based Pharmacokinetic Model

Therapeutic antibodies are often prescribed off-label to pregnant patients to treat inflammatory, autoimmune, or malignant conditions. Despite their broad use, the extent of fetal exposure to such therapeutic antibodies and the risk to fetal development remain largely unknown. Given the ethical chal...

Full description

Saved in:
Bibliographic Details
Published inClinical pharmacology and therapeutics Vol. 118; no. 2; p. 394
Main Authors Kardouh, Miramar Sami, Dunlap, Tyler C, Zhong, Rui, Tiley, Jacqueline B, Cao, Yanguang
Format Journal Article
LanguageEnglish
Published United States 01.08.2025
Subjects
Online AccessGet more information

Cover

Loading…